|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Einsiedlerstrasse 34, Wädenswil, CH
|
|
Numab Therapeutics is an oncology-focused biopharmaceutical company based in the Zurich-area, Switzerland. At Numab, we are writing the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH™ technology platform we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind. Our lead product was designed to balance potent anti-tumor immunity with a desirable safety profile by targeting 4-1BB, PD-L1 and Human Serum Albumin simultaneously. We believe meeting the highest quality standards in every step of the drug design process matters and will result in better patient outcomes.
|
Numab Therapeutics AG Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}.{last} | [email protected] |
100%
|
The widely used Numab Therapeutics AG email format is {f}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Numab Therapeutics AG customer service number in your country click here to find.
David Urech is the CEO of Numab Therapeutics AG. To contact David Urech email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.